Skip to main content

Table 6 Public Spending on 3 Orphan Medicinal Products with Reimbursement in 5 EU Countries in 2013–14

From: The European challenges of funding orphan medicinal products

  Average spending per 100,000 inhabitants in 2013–14 Ratio of spending compared to the average of 5 countries
Belgium 94,744 € 1,39
Bulgaria 33,387 € 0,49
Czech Republic 80,526 € 1,18
Poland 51,565 € 0,76
Slovenia 80,699 € 1,18